Sawai Group Holdings Co., Ltd.
[Sawai Group] FY2026 Earnings Results | Revenue of JPY 201.6 billion (6.7% increase)
The Sawai Group's consolidated results for the fiscal year ending March 2026 show revenue of JPY 201.6 billion (up 6.7% YoY), operating profit of JPY 15,894 million (up 292.5%), and net income attributable to owners of the parent of JPY 10,438 million (down 12.8%). Although core operating profit remains strong at JPY 24,778 million (down 3.6%), dividends are increased, and forecasts for the fiscal year ending March 2027 remain solid.
Key Figures
- Revenue: JPY 201.6 billion (up 6.7% YoY)
- Net income attributable to owners of the parent: JPY 10,438 million (down 12.8%)
- Forecast for FY2027 revenue: JPY 208.4 billion (up 3.3%)
AI要約
Financial Overview
The Sawai Group recorded revenue of JPY 201.6 billion (up 6.7%), operating profit of JPY 15,894 million (up 292.5%), pre-tax profit of JPY 14,273 million (up 351.5%), and net income attributable to owners of the parent of JPY 10,438 million (down 12.8%) for the fiscal year ending March 2026. Core operating profit was JPY 24,778 million (down 3.6%), influenced by gains and losses related to the divestment of non-core US operations. Although revenue remained steady, net income decreased. The company aims to continue growth and stable operations based on its medium-term management plan.
Outlook and Impact on Shareholders
The consolidated earnings forecast for the fiscal year ending March 2027 projects revenue of JPY 208.4 billion (up 3.3%), core operating profit of JPY 29,600 million (up 19.5%), operating profit of JPY 27,200 million (up 71.1%), and net income of JPY 18,600 million (up 78.2%). Dividends are also expected to increase, strengthening shareholder returns. The company plans to expand its pharmaceutical business steadily, introducing new products and managing costs to improve profitability.
Sawai Group Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
